Emergent BioSolutions has received a $56 million contract extension to supply the US government with doses of the ACAM2000 vaccine.
Human population immunity to such viruses has been waning globally since smallpox was eradicated, which is likely why they are being seen more often, the authors say.
The freeze-dried Jynneos formulation will be easier to store and transport and will have a longer shelf life.
National stockpiles of smallpox vaccines, antivirals, and drugs are "imperfect" and limited, the authors say.
Bavarian Nordic has received a US government contract for $120 million to manufacture more of its Jynneos smallpox/mpox vaccine.
Upwards of 700,000—perhaps as many as 1.6 million—US COVID-19 survivors haven't recovered their sense of smell after more than 6 months, according to a research letter yesterday in JAMA Otolaryngology-Head & Neck Surgery.
New research from the Mayo Clinic shows monoclonal antibodies reduce the risk of hospitalization 77% in 1,395 patients who had breakthrough COVID-19 infections. The research was published yesterday in the Journal of Infectious Diseases.
A survey of 164 New York physicians found that one in five were severely distressed during their first COVID-19 triage decisions and last-minute training did not appear to alleviate stress, according to a study yesterday in Disaster Medicine and Public Health Preparedness.
Direct COVID-19 deaths may be more than double previous estimates, according to a report yesterday by the University of Washington's Institute for Health Metrics and Evaluation (IHME).
A study published today in the Centers for Disease Control and Prevention's (CDC's) Morbidity and Mortality Weekly Report (MMWR) highlights factors that may increase the risk of infection with SARS-CoV-2, the virus that causes COVID-19, among US poultry facility workers—especially those who are foreign-born.
